Moreover, DRD3 expression and function are down-regulated during stress and depression, and antidepressant therapy can reverse these changes, suggesting that enhanced DAergic neurotransmission mediated by DRD3 down-regulation is involved in the adaptive changes underlying antidepressant activity. Here, DRD3 is linked to depressive symptom measurement.